H.‐Christian von Büdingen

Author

University of California, San Francisco ORCID

Also Known As

H -Christian von Büdingen, H-Christian von Büdingen, H. Büdingen, H. J. Büdingen, H. Von Budingen, H.-C. Büdingen, H.-C. von Büdingen, H.-Christian von Büdingen, H.‐Christian von Büdingen, Hans Christian von Büdingen

Publications

6.2K

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco University Hospital of Zurich University of Zurich University Hospital of Basel Roche (Switzerland)

About

H.‐Christian von Büdingen is an author at University of California, San Francisco specializing in medicine, neuroimmunology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	1.8K
2	Social Sciences	4	4	437
3	Health Sciences	3	3	641
4	Allergy	1	1	102
5	Biology	1	1	15

H.‐Christian von Büdingen

Publications

Citations

H-Index

Page 1

	Year	Citations
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial Ari Green, Jeffrey M. Gelfand, Bruce Cree, The Lancet Crossover TrialNeurological DisorderNeurological ProgressClinical TrialsNeurological Monitoring	2017	548
Long‐term evolution of multiple sclerosis disability in the treatment era Bruce Cree, Pierre‐Antoine Gourraud, Carolyn Bevan, Annals of Neurology	2016	430
Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery Feng Mei, Klaus Lehmann‐Horn, Yun‐An Shen, eLife Inflammatory DemyelinationImmunologyPeripheral NervesSocial SciencesNeuroinflammation	2016	308
Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients Arumugam Palanichamy, Sarah Jahn, Dorothee Nickles, The Journal of Immunology	2014	280
B cell exchange across the blood-brain barrier in multiple sclerosis H.‐Christian von Büdingen, Tracy C. Kuo, Marina Sirota, Journal of Clinical Investigation Adaptive Immune SystemNeurological DisorderImmunologyPathologyImmunotherapy	2012	231
Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis Arumugam Palanichamy, Leonard Apeltsin, Tracy C. Kuo, Science Translational Medicine	2014	220
Naive antibody gene-segment frequencies are heritable and unaltered by chronic lymphocyte ablation Jacob Glanville, Tracy C. Kuo, H.‐Christian von Büdingen, Proceedings of the National Academy of Sciences	2011	193
Spinal cord gray matter atrophy correlates with multiple sclerosis disability Regina Schlaeger, Nico Papinutto, Valentina Panara, Annals of Neurology	2014	186
Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis Patrice H. Lalive, Til Menge, Cécile Delarasse, Proceedings of the National Academy of Sciences Neurological DisorderImmunologyPathologyOther Myelin ConstituentsNeuroinflammation	2006	172
Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination H.‐Christian von Büdingen, Stephen L. Hauser, Jean‐Christophe Ouallet, European Journal of Immunology ImmunologyPathologyHuman Multiple SclerosisConformational EpitopesImmunotherapy	2004	102

Page 1